Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.
業界リーダー
同社の収益は業界をリードしており、最新の年間収益はUSD 293.96Bです。
高成長
同社の収益は過去3年間にわたり着実に増加しており、年平均で23.21%の成長率を示しています。
高配当
同社は高配当銘柄であり、最新の配当性向は27.58%です。
適正水準
同社の最新のPEは31.27で、過去3年間の水準と比較して適正圏にあります。
機関投資家の売り越し
最新の機関投資家の保有株数は191.45M株で、前四半期比で0.10%減少しています。
バンガードが保有
スター投資家バンガードは本銘柄を22.40M株保有しています。